MondayOct 23, 2023 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Reports Fr8Fleet Carrier Capacity Growth; Adds Advanced Tracking Capabilities to Fr8App with Successful Geotab Open API Integration

Fr8Tech has witnessed a rise in carrier capacity, reporting a 60.8% year-over-year increase in August 2023 carrier capacity levels compared to August 2022 The average capacity levels through August rose 55.7% year-to-date Luisa Lopez, Fr8Tech COO, attributed this growth to the company’s commitment to delivering quality services even during periods of downtime and securing high-quality carrier capacity Fr8Tech also announced that Fr8App recently completed an integration with Geotab’s open API The integration now allows Fr8App users to experience easy and precise tracking and monitoring of shipments Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a North American transportation logistics technology company offering…

Continue Reading

MondayOct 23, 2023 9:45 am

Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Provides Insights on Definitive Agreement to Combine with GEDi Cube to Transform Medicine

Combined company brings together two innovative platforms in AI and biotherapeutics to offer comprehensive solutions spanning early cancer detection, diagnostic insights, and targeted immunotherapies The decision to join forces resulted from a carefully considered strategy to combine strengths and synergize work to elevate therapeutic efficacy and patient care By joining forces, the two technology divisions will collaborate to push new boundaries in precision diagnostics and targeted treatments GEDi Cube’s AI algorithms, trained using real-world data, could guide and accelerate Renovaro’s therapy development Renovaro’s intimate knowledge about vital aspects of the immune system and how cancers could respond to treatment may…

Continue Reading

MondayOct 23, 2023 9:00 am

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Promising Results in Its Pursuit of Safe, Effective Treatments for Large, Underserved Population of Plaque Psoriasis Patients

Scinai announced positive results suggesting the therapeutic potential of its anti-IL-17 VHH antibodies (NanoAbs) in treating plaque psoriasis The preclinical study showed that the introduction of the NanoAbs downregulated the standard molecular markers S100A7, CXCL1, and CCL20, that are often overexpressed in plaque psoriasis The study also revealed that the outer skin layers regained their normal appearance The company aims to provide safe, efficacious, specific, and more convenient treatment for the large and underserved population of mild to moderate plaque psoriasis patients Scinai is conducting an ex-vivo study to evaluate the anti-IL-17 NanoAbs in a full human skin model induced…

Continue Reading

FridayOct 20, 2023 10:30 am

Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Increases Output as Canadian Oil Production Hits Record High

International Energy Agency (“IEA”) forecasts record oil production in Canada, global demand and prices expected to rise as Russia and Saudi Arabia cut production Prospera Energy operates 42,000+ cumulative acres, estimates approximately 8% of over half a billion available barrels was recovered using traditional vertical well technology The company completed Phase 1 of restructuring plan, production expanded from 80 to 1,200 BOE and NPV increased from $3 million to $72 million Phase 2 focuses on horizontal well transformation, piloting an enhanced oil recovery application, executing liability management objectives, and furthering ESG initiatives The company recently completed four horizontal wells of…

Continue Reading

FridayOct 20, 2023 9:45 am

6G Satellite Connectivity Research Uses D-Wave Quantum Inc. (NYSE: QBTS) Solutions for Enhanced Network Optimization

LG’s South Korean mobile network operator LG U+ collaborated with KAIST (Korea Advanced Institute of Science and Technology) and Korea’s Qunova Computing to advance 6G satellite networks using the power of D-Wave's quantum computing solutions D-Wave's annealing quantum computer has helped the companies successfully develop seamless connectivity of ground-to-satellite links and inter-satellite links D-Wave is the world’s first commercial supplier of quantum computers and is helping customers apply practical quantum computing solutions to solve highly complex computational problems today D-Wave Quantum (NYSE: QBTS) recently announced that LG U+, under the leadership of CEO Hyeon Sik Hwang, worked with the Korea…

Continue Reading

FridayOct 20, 2023 9:00 am

GEMXX Corp. (GEMZ) On Track to Exceed Estimated Production for the Season Following 2nd Clean-Out and Recording of Gold Production at Snow Creek Mine Site

GEMXX Corp., producer and distributor of gold and gems, draws on its own mining assets to manufacture its colorful jewelry, unique in the jewelry industry, and is the leading producer of top-quality finished Ammolite products. GEMXX just completed its second clean-out and recording of gold production at its Snow Creek Mine site, yielding 172.3 ounces of gold from 18,000 cubic yards of material, resulting in 0.96 ounces per 100 cubic yards. 2023 gold production is a huge milestone for the company, as it looks to de-risk its revenues and complement its Ammolite production, and the company is on track to…

Continue Reading

ThursdayOct 19, 2023 11:00 am

GolfLync Inc. Heats the Chill of Changing Weather for Golfing Enthusiasts Across the Nation

GolfLync makes it possible for golfers to make connections in any season through a social media platform created by golfers for golfers GolfLync's VCGs allow members to easily find local golf communities and public golf clubs in their area As a revolutionary golf social media platform – GolfLync brings together the golfing community to foster relationships and build a greater sense of community As the leaves fall and the seasons shift from warm to cool – new opportunities for comfortable golfing open up around the country. And golfing partners can change along with the seasons. If you enjoy a tee…

Continue Reading

ThursdayOct 19, 2023 10:30 am

SOHM, Inc. (SHMN) Completes Acquisition of ABBIE Gene-editing Tech, Begins Preparations to Commercialize Solutions for Heart Disease

Generic drug manufacturer and distributor SOHM has completed the LOI process to acquire stem cell gene-editing technology ABBIE from CGA Intellectual Holdings Inc. The company expects the technology to provide it with commercialization revenues as it builds a solution for gene-enhanced stem cells that can be used to treat a number of diseased organs, beginning with heart ailments The edited-gene cells are expected to be used for in-human clinical trials by 2025, using a non-viral vector for inserting the genes into patients’ bodies SOHM believes the technology will provide it with a competitive advantage in a market expected to grow…

Continue Reading

ThursdayOct 19, 2023 10:00 am

Diamond Lake Minerals Inc. (DLMI) Is ‘One to Watch’

Diamond Lake Minerals’ shares offer investors a traditional vehicle to gain exposure to the opportunity presented by regulated digital securities The company’s core objectives include generating substantial revenue streams, maintaining lean operations, ensuring profits and creating significant shareholder value As of August 2023, outstanding shares of the company numbered slightly more than 23.5 million The company has identified a roadmap of target acquisitions to fuel the growth and profitability of its business model Diamond Lake Minerals (OTC: DLMI) is a multi-strategy operating company offering traditional investors an entry point to the future of digital securities. The company’s goal, through its…

Continue Reading

ThursdayOct 19, 2023 9:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Raised $1.6 Million in Latest Investment Round; Looks to Advance DehydraTECH(TM) Research Operations

Lexaria, a global innovator in drug delivery platforms, recently announced that it had entered into a securities purchase agreement with a single health-focused institutional investor The agreement is for the purchase of 1,618,330 shares of common stock at $0.97 per share, with gross proceeds amounting to approximately $1.6 million The raised funds will be integral to Lexaria advancing its operations, inching it closer to FDA approval for its patented DehydraTECH(TM)-processed CBD for the potential treatment of hypertension It will also help assert Lexaria’s position as a leader in the market, even as it pushes the envelope in terms of research…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered